0001600132-20-000102.txt : 20200914 0001600132-20-000102.hdr.sgml : 20200914 20200914160328 ACCESSION NUMBER: 0001600132-20-000102 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200910 FILED AS OF DATE: 20200914 DATE AS OF CHANGE: 20200914 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Moura Andre V. CENTRAL INDEX KEY: 0001631831 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36845 FILM NUMBER: 201173207 MAIL ADDRESS: STREET 1: C/O NEW MOUNTAIN CAPITAL, LLC STREET 2: 787 SEVENTH AVENUE, 49TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Bellerophon Therapeutics, Inc. CENTRAL INDEX KEY: 0001600132 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473116175 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 184 LIBERTY CORNER ROAD, SUITE 302 CITY: WARREN STATE: NJ ZIP: 07059 BUSINESS PHONE: 908-574-4770 MAIL ADDRESS: STREET 1: 184 LIBERTY CORNER ROAD, SUITE 302 CITY: WARREN STATE: NJ ZIP: 07059 FORMER COMPANY: FORMER CONFORMED NAME: Bellerophon Therapeutics LLC DATE OF NAME CHANGE: 20140213 4 1 wf-form4_160011379465128.xml FORM 4 X0306 4 2020-09-10 0 0001600132 Bellerophon Therapeutics, Inc. BLPH 0001631831 Moura Andre V. C/O NEW MOUNTAIN CAPITAL, L.L.C. 787 SEVENTH AVENUE, 49TH FLOOR NEW YORK NY 10019 1 0 0 0 Stock Option (right to buy) 10.12 2020-09-10 4 A 0 6509 10.12 A 2021-09-10 2030-09-10 Common Stock 6509.0 13472 D /s/ Andre V. Moura 2020-09-14